Initiation of Phase 1b Study of GT-02287 in Parkinson’s patients expected by end of 2024BETHESDA, Md., Nov. 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage ...

Heart muscle cells grown from stem cells show promise in monkeys with a heart problem that typically results from a heart ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

They also enable us to do so at scale, something that it not feasible or ethical in larger animals ... disease models, ...

Parkinson’s, and Charcot-Marie-Tooth disease. The company’s lead candidate for ALS, AV-016, “has demonstrated the greatest ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in ...

Assistant professors in the Department of Neurology, Patricia Aguilar Calvo, Ph.D., and Mariangela Scarduzio, Ph.D., have been awarded research grants from the American Parkinson Disease ...

Parkinson's disease is a challenging condition that can ... anatomy and genetics allow us to use the zebra finches as a model for human speech and voice." The researchers recorded the birds ...

Nintendo will sell the upcoming paid version of its smartphone Animal Crossing app for £18 ($20) after the closure of its current free-to-play edition next month. However, to start with ...

“Genetic variants associated with larger brain volumes in key brain regions also increase the risk of Parkinson’s disease, while variants linked to smaller brain volumes in key regions are ...